BBB National Programs Decision Summaries
BBB National Programs provides summaries of all case decisions from the National Advertising Division (NAD), National Advertising Review Board (NARB), Children’s Advertising Review Unit (CARU), Direct Selling Self-Regulatory Council (DSSRC), and Digital Advertising Accountability Program (DAAP). Subscribe to receive a weekly wrap-up of published case decisions in your inbox.
- All
-
9/23/2014 - NAD Recommends Cerebral Success Discontinue Certain Claims for SmartX Dietary Supplement
The National Advertising Division has recommended that Cerebral Success, maker of the dietary supplement “SmartX,” discontinue a wide range of claims challenged by the Council for Responsible Nutrition (CRN). -
9/16/2014 - NAD Finds Hill’s Pet Nutrition Violated NAD/NARB Procedures in Outreach Campaign to Bloggers
The National Advertising Division (NAD) has determined that Hill’s Pet Nutrition violated the procedures that govern the advertising industry’s system of self-regulation by seeking to use for promotional purposes decisions reached by the NAD and the National Advertising Review Board (NARB). -
9/11/2014 - NAD Recommends P&G Discontinue Certain Claims for ‘Olay Sensitive Body Wash’ Following Unilever Challenge
The National Advertising Division has recommended that The Procter & Gamble Company, the maker of Olay Sensitive Body Wash, discontinue claims that convey the unsupported message that Dove Sensitive Skin Body Wash, a competing product made Unilever United States, Inc., is “harsh.” Further, NAD recommended that P&G modify claims that Dove Sensitive Skin Body Wash can dry one’s skin over time. -
9/03/2014 - NAD Recommends Virtua Health System Discontinue Challenged Claims for ‘Quad-Sparing’ Knee Replacement Surgery
The National Advertising Division has recommended that Virtua Health System discontinue certain advertising claims for the hospital chain’s minimally invasive, “quad-sparing” knee-replacement surgery. -
8/28/2014 - NAD Recommends Verizon Better Disclose Basis for Certain Claims following Cablevision Challenge
The National Advertising Division has recommended that Verizon Communications, Inc., modify certain advertising claims, including claims that are based on PC Magazine surveys, to better disclose the basis for the claims. -
8/27/2014 - NAD Finds P&G Can Support Certain Claims for Olay ‘Ultra Moisture Body Wash,’ But Recommends Company Discontinue ‘Lotion’ Claims
The National Advertising Division has determined that The Procter & Gamble Company can support claims that Olay Ultra Moisture Body Wash leaves more moisturizer on the skin than Dove Deep Moisture, a competing product made by Unilever United States, Inc. -
8/21/2014 - NAD Recommends Chobani Discontinue ‘Farmland’ Yogurt Commercial, Modify Facebook Ads
The National Advertising Division has recommended that Chobani, Inc., discontinue its “Farmland” commercials, the centerpiece of the company’s campaign to promote its “Simply 100” Greek yogurt, and modify certain online adverting. NAD noted, however, that the advertiser was entitled to promote its use of natural sweeteners as compared with the artificial sweeteners used by certain other yogurt brands. -
8/13/2014 - NAD Recommends eHarmony Discontinue Claims Challenged by Match.com
The National Advertising Division has recommended that eHarmony, Inc., discontinue certain “#1” advertising claims for the company’s dating website, eHarmony.com, including “#1 Most Marriages,” “#1 Most Enduring Marriages,” and “#1 Most Satisfying Marriages.” -
8/12/2014 - NAD Recommends ConAgra Modify or Discontinue ‘Steam, Not Lye’ Claim Challenged by Red Gold
The National Advertising Division has recommended that ConAgra Foods discontinue the claim “We peel our tomatoes with steam, not lye,” or modify the claim to make clear that lye-peeled tomatoes are neither unsafe nor unhealthy. -
8/06/2014 - NAD Finds Chattem Can Support Challenged Claims for ‘Nasacort’ Following Merck Challenge
The National Advertising Division has determined that sanofi-aventis, sanofi-aventis U.S. and Chattem, Inc., can support certain advertising claims for “Nasacort Allergy 24HR,” an over-the-counter allergy relief medication. The claims were challenged by MSD Consumer Care, Inc., a/k/a Merck Consumer Care.